Clinical Therapeutics

Editorial comment
pp. 1149-1150(2)
Author: Walson P.D.

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review
pp. 1151-1168(18)
Authors: Malinowski J.M.; Bolesta S.

Clinical experience with pantoprazole in gastroesophageal reflux disease
pp. 1169-1185(17)
Author: Avner D.L.

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
pp. 1186-1203(18)
Authors: Losartan Trial Investigators; Manolis A.J.; Grossman E.; Jelakovic B.; Jacovides A.; Bernhardi D.C.; Cabrera W.J.; Watanabe L.A.; Barragan J.; Matadamas N.; Mendiola A.; Woo K.S.; Zhu J.R.; Mejia A.D.; Bunt T.; Dumortier T.; Smith R.D.

Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting
pp. 1204-1212(9)
Authors: Barnebey H.; Kwok S.Y.

A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged =<65 years with mild to moderate hypertension
pp. 1213-1224(12)
Author: Lacourciere Y.

A comparison of tazarotene 0.1 2.25568e-311el once daily plus mometasone furoate 0.1
pp. 1225-1238(14)
Authors: Guenther L.C.; Poulin Y.P.; Pariser D.M.

Retrospective analysis of the safety profile of oral and intravenous ciprofloxacin in a geriatric population
pp. 1239-1250(12)
Authors: Heyd A.; Haverstock D.

Dear Dr. Walson:
pp. 1251-1252(2)
Author: Gold M.

Dr. Mosnier replies:
pp. 1252-1252(1)
Author: Mosnier M.